Deans' stroke musings: Motus Nova voted 'Most Innovative Tech Company of 2019' by TAG for Increasing Access to Stroke Rehab with Affordable Robotic Devices for at Home Use

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, January 1, 2020

Motus Nova voted 'Most Innovative Tech Company of 2019' by TAG for Increasing Access to Stroke Rehab with Affordable Robotic Devices for at Home Use

Notice absolutely no research to back this up or any factual information on rehab results. Their mission is just to deliver their product, saying nothing about it actually working. So making money is their goal, nothing to do with getting survivors recovered.

Motus Nova voted 'Most Innovative Tech Company of 2019' by TAG for Increasing Access to Stroke Rehab with Affordable Robotic Devices for at Home Use

News provided by

Motus Nova

Dec 31, 2019, 18:30 ET

ATLANTA, Dec. 31, 2019 /PRNewswire/ -- Stroke affects more than 15 million people worldwide. Direct access to clinically proven therapies and a full recovery is out of reach for most survivors leading to a lifetime of impairment.
"Our mission is to deliver neuro-rehab in every home through robotic exoskeletons guided by AI. Latin for 'movement anewed', Motus Nova envisions a world where survivors of stroke live without impairment. We believe a brain injury or stroke is meant to be overcome and does not define your future," said Motus Nova CEO David Wu.

Dr. Daniel Schlatterer, M.D., is an orthopedic surgeon and a stroke survivor who has used the Motus Nova system with good results. "I'm an orthopedic surgeon in a trauma center in downtown Atlanta, and a little over two years ago at the age of 48 had a stroke. I've tried just about everything and I can tell you that this has helped and made a difference. I've seen improvements in my wrist motion since I've started this. I'm making steady progress in improvement."

The Technology Association of Georgia, one of the country's largest technology associations with 30,000+ members, announced Motus Nova as its Most Innovative Tech Company of 2019. The award recognizes a Georgia-based technology company for its innovation, financial impact, likelihood of success, and its efforts at spreading awareness of state's technology initiatives throughout the U.S. and globally. Motus Nova competed against 40 of the best startups and companies in Georgia and was judged by more than 1,300 prominent C-level executives, entrepreneurs, and academic leaders from around the world in discussions and actions centered on the global trends that are sparking and disrupting the tech community.
Motus Nova has revolutionized healthcare rehabilitation for stroke survivors. Developed in conjunction with the top hospitals in the U.S., Motus Nova's patented FDA Class I rehabilitation robotics are used in over 170 clinics and hospitals. Advanced sensors, predictive analytics, and intensive, task-guided video games, have helped Motus Nova deliver personalized healthcare rehabilitation for thousands of stroke survivors over the past decade.
Building on clinically proven technology, Motus Nova has developed the first and only "active assist" rehabilitation system that is both affordable and portable enough to be used independently for in-home therapy. The robotic exoskeleton is guided by AI and leverages machine learning to create personalized care and facilitate motor function recovery. Motus Nova seeks to close the gap in treatment access by placing the Hand and Foot Mentor devices directly in the home, allowing people to take charge of their recovery from the comfort of their home at up to five times faster and a fraction of the cost of conventional physical therapy.
SOURCE Motus Nova